DE
INSIDER · TVTX · Travere Therapeutics, Inc. · CHIEF EXECUTIVE OFFICER
Dube Eric M
Every open-market transaction filed under this name, Sep 15 to Oct 15.
Filings
11
0 buys · 11 sells
Bought
—
open market, at cost
Sold
$38.5M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 15 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 78,400 | $55.02 | $4.3M | −4.7% |
| Oct 15 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 37,270 | $54.20 | $2M | −3.3% |
| Oct 15 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 128,065 | $52.97 | $6.8M | −1.0% |
| Sep 17 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 6,802 | $64.95 | $442K | −19.3% |
| Sep 17 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 101,691 | $64.59 | $6.6M | −18.8% |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 96,125 | $63.64 | $6.1M | −17.6% |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 99,716 | $63.26 | $6.3M | −17.1% |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 270 | $65.31 | $18K | −19.7% |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 3,102 | $63.64 | $197K | −17.6% |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 28,796 | $62.66 | $1.8M | −16.3% |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER | Sell | 63,498 | $61.99 | $3.9M | −15.4% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.